2009 Vienna - European Society of Human Genetics

Keyword Index
and Russe: P03.180
Oxidative Deamination: P06.176
Oxidative stress: P03.197, P09.095
Oxide nitric synthase: P17.37
P
p19Arf-p53 pathway: S14.1
p21: P06.021
p53 gene: P06.154
p53 germ-line mutation: P06.052
p53, c-erb, c-myc: P07.11
p53: C06.3, P06.041, P06.043, P07.07,
P10.68
p63: P02.014
p75: P14.15
PAC clone: P11.099
pachygyria: P03.131
PAD: P17.36
pain sensitivity: P09.010
Pancreatic hypoplasia: P02.081
PANDAS: P09.124
PANK2: C14.5
Papillary Throid Carcinoma: P11.091
paraganglioma: P06.085
Parallel sequencing: P06.027
parametric linkage: P08.49
paranoid schizophrenia: P09.096
parental consanguinity: P03.201
Parental origin: P03.055, P03.059
parental/meiotic origin: P02.002
parent-of-origin effect: P10.38
parital trisomy 15: P03.126
PARK13: P17.55
Parkin gene: P11.108, P17.56
Parkinson disease: S10.2
Parkinson: C17.1, P17.50, P17.60, P17.61
Parkinson’s disease: C12.2, P09.106,
P11.092, P13.42, P17.51, P17.52,
P17.54, P17.55, P17.56, P17.57, P17.58,
P17.59
PARP1: P06.016
partial duplication chromosome 13q:
P03.104
partial duplication: P03.110
Partial trisomy 15q: P03.095
partial trisomy 19p: P03.105
partial trisomy 21: P03.021
Partial trisomy 9p: P03.095
Partial trisomy of 1q42: P03.111
partial trisomy: P03.162, P05.23
paternal age: P03.018
paternal UPD14: P03.147
Pathogenesis: C16.5, P09.097
pathology: P06.105
pathway analysis: P09.041
pathway: P09.025
Pathways: C05.5
Patient information: P01.29
PAX3: P03.068
PAX5: P08.60
Pax6: P11.093
PCCA: P12.133
PCOL2 polymorphism: P09.035
PCR: P04.33, P11.071
PCR-RFLP analysis: P12.130
PCR-RFLP: P10.26, P10.68
PCR-SSCP: P06.127, P06.134
PCSK9: P12.058
PD: P09.046, P09.071, P17.50
PDE6B: P16.02
PDGH: P09.053
pedigree: P08.49, P09.065
Pejvakin: P10.17
Pelizeaus-Merzbacher Disease: P12.128
Pelvic organ prolapse: P09.097
Penetrances: P06.151
Perforin, Munc13-4, Syntaxin 11 genes:
P06.203
Performance: P15.06
Periodontitis: C10.5, P08.50, P09.050
Peritoneal dialysis: P03.042
persistent hyperplastic primary vitreus:
P05.41
personality traits: P09.088
personalize the reproductive risk: P04.08
Pesticide: P03.044
Peters anomaly: P03.061
Peutz- Jeghers syndrome: P12.129
Peutz-Jeghers syndrome: P06.164,
P06.165
PGC1A polymorphism: P10.69
PGD/PGS: P05.44
PGD: P05.48, P05.51
PGD-HLA: P05.49
p-glycoprotein 170: P10.52
PGRN mutation: P09.045
pgrn: P02.040
Ph: P06.188
PHACE(S): P02.092
Pharmacogenetic association studies:
P08.51
Pharmacogenetic investigations: P11.045
Pharmacogenetics: P06.155, P08.51,
P09.122, P17.69
pharmacogenomics: P06.097, P06.207
phased haplotypes: P11.094
phenotype heterogeneity: P12.128
phenotype variability: P03.179
phenotype: C15.4, C18.4, P03.130,
P06.036, P08.22, P11.047, P11.048
phenotypic heterogeneity: P12.055
Phenylalanine Hydroxylase: P12.130
phenylketonuria: P01.38, P13.43
PHLPP: P06.069
phosphorylation: P02.168
photosensivity: P02.023
phylogenetic tree reconstruction: P11.079
physical exercises: P14.06, P17.44
physical performance: P09.043, P10.69
physiotherapy: P14.06
PI3K/Akt: P06.069, P06.179
PICH: PL2.5
Pierre Robin sequence: P02.089
Pigmentented Hypertrichosis with IDDM:
PL2.3
PIN1: P08.05
Pitt Hopkins syndrome: C02.4
PITX2: P02.013
PKD: P02.093
PKD1: P12.021
PLA2G6: P12.101
PLAGL1: P04.17
plakophilin-2: P16.18
plasma cell-free DNA: P06.089
Plasma lipids: P09.115
plekstrin homology domain: C03.4
Plott syndrome: P02.094
PLP1 gene: P12.128
PLS3: P12.149
plurimalformative syndrome: P03.119
plutonium: P03.045
plymorphism: P17.13
PMD: P08.45
PML - promyelocytic leucemia gene:
P06.156
PMM2: P12.028
PMP22 and Cx32 gene: P16.33
PMS2: P06.157
PND: P05.01, P05.24
pneumonia-related sepsis: P09.098
podocin: P12.119
Poland- Möbius syndrome: P02.096
Poland Syndrome: P02.095
polar body diagnosis: P05.50
POLG gene: P13.02
POLG: P02.097
POLG1: P13.44
POLH: C06.1
policy analysis: P01.06
Policy: P01.41, P05.51
Polish population: P06.031, P12.100
Polycomb Group Proteins: P06.180
polycystic ovary syndrome: P13.16
polyglutamine and polyproline: P10.43
polyglutamine disorder: P10.74
polyglutamine expansions: P12.116
polyglutamine: C03.6
polymalformation syndrome: C11.5